Michael Ridley
(Former)
1 - 3 out of 3Page size: 10
Publications
- 2017
- Published
Gain-of-function mutation of tristetraprolin impairs negative feedback control of macrophages in vitro, yet has overwhelmingly anti-inflammatory consequences in vivo.
John O'Neil, Ewan Ross, Michael Ridley, Dalya Rosner, Timothy Smallie, Christopher Buckley & Andrew R. Clark, Jun 2017, In: Molecular and Cellular Biology. 37, 11, e00536-16.Research output: Contribution to journal › Article › peer-review
- Published
Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression
Amy Naylor, John O'Neil, Michael Ridley, Timothy Smallie, Tina Tang, Jason Turner, Andrew Filer, Christopher Buckley & Andrew R. Clark, Mar 2017, In: Annals of the Rheumatic Diseases. 76, 3, p. 612-619Research output: Contribution to journal › Article › peer-review
- 2015
- Published
Dual-specificity phosphatase 1 and tristetraprolin cooperate to regulate macrophage responses to lipopolysaccharide
Timothy Smallie, Ewan Ross, Dalya Rosner, Michael Ridley, Christopher Buckley & Andrew R. Clark, 1 Jul 2015, In: Journal of Immunology. 195, 1, p. 277-288Research output: Contribution to journal › Article › peer-review